Juliette Saillard

1.2k total citations
8 papers, 142 citations indexed

About

Juliette Saillard is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Juliette Saillard has authored 8 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Virology and 3 papers in Emergency Medicine. Recurrent topics in Juliette Saillard's work include HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (4 papers) and HIV-related health complications and treatments (3 papers). Juliette Saillard is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (4 papers) and HIV-related health complications and treatments (3 papers). Juliette Saillard collaborates with scholars based in France, Denmark and United Kingdom. Juliette Saillard's co-authors include Clotilde Allavena, François Raffi, Fleur Hudson, Abdel G. Babiker, Geneviève Chêne, Remko van Leeuwen, Jesper Grarup, José Ramón Arribas, Elizabeth C. George and Andrea Antinori and has published in prestigious journals such as The Lancet, The Lancet Neurology and British Journal of Clinical Pharmacology.

In The Last Decade

Juliette Saillard

6 papers receiving 140 citations

Peers

Juliette Saillard
Havilland Campbell United States
Pedro Cahn Argentina
Anthony Scarsella United States
Sara Lino Portugal
Dannae Brown United States
Natasja van Holten Netherlands
Lizette Santiago United States
Johannes Lombaard United States
Godson Oguchi United States
Havilland Campbell United States
Juliette Saillard
Citations per year, relative to Juliette Saillard Juliette Saillard (= 1×) peers Havilland Campbell

Countries citing papers authored by Juliette Saillard

Since Specialization
Citations

This map shows the geographic impact of Juliette Saillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliette Saillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliette Saillard more than expected).

Fields of papers citing papers by Juliette Saillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliette Saillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliette Saillard. The network helps show where Juliette Saillard may publish in the future.

Co-authorship network of co-authors of Juliette Saillard

This figure shows the co-authorship network connecting the top 25 collaborators of Juliette Saillard. A scholar is included among the top collaborators of Juliette Saillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliette Saillard. Juliette Saillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Fougerou‐Leurent, Claire, Christelle Delmas, Juliette Saillard, et al.. (2023). Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20–15 DisCoVeRy study. Contemporary Clinical Trials. 131. 107267–107267.
2.
Abé, Emuri, Lambert Assoumou, Pierre de Truchis, et al.. (2020). Pharmacological data of a successful 4‐days‐a‐week regimen in HIV antiretroviral therapy (ANRS 162‐4D trial). British Journal of Clinical Pharmacology. 87(4). 1930–1939. 2 indexed citations
4.
Saillard, Juliette, et al.. (2017). Bacterial keratitis treated by strengthened antibiotic eye drops: An 18 months review of clinical cases and antibiotic susceptibilities. Annales Pharmaceutiques Françaises. 76(2). 107–113. 12 indexed citations
5.
Raffi, François, Abdel G. Babiker, Laura Richert, et al.. (2014). Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.. The Lancet Neurology. 384(9958). 1 indexed citations
7.
Bernardino, José Ignacio, Amanda Mocroft, Patrick Mallon, et al.. (2014). Changes in Bone Mineral Density (BMD) over 96 Weeks on Darunavir/Ritonavir (DRV/r) + Raltegravir (RAL) or DRV/r + Tenofovir/Emtricitabine (TDF/FTC). Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles).
8.
Raffi, François, et al.. (2014). COL05-01 RAL + DRV/r est non inférieur à TDF/FTC + DRV/r en traitement initial antirétroviral : essai NEAT001/ANRS143. Médecine et Maladies Infectieuses. 44(6). 9–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026